The diverged homeobox gene TLX1 (for T-cell leukaemia homeobox 1, previously known as HOX11 or TCL3) is activated in c.5-10% of childhood and up to 30% of adult T-cell acute lymphoblastic leukaemia (T-ALL) cases, most frequently by t(10;14)(q24;q11) and t(7;10)(q35;q24) chromosomal translocations which juxtapose the intact TLX1 coding region downstream of T cell receptor TCRd (TRD@) or TCRb (TCRB) gene regulatory sequences. TLX1 + T-ALL samples are virtually all arrested at the early cortical (CD1 + ) CD4 + CD8 + ''double-positive'' (DP) stage of thymocyte development (Ferrando et al, 2002; Asnafi et al, 2004) .
We previously showed that retroviral expression of TLX1 in primary murine hematopoietic-repopulating cells induced T-ALL-like malignancies in engrafted mice (Hawley et al, 1997) . However, the murine model system did not perfectly reproduce the phenotype of human TLX1 + T-ALL (Owens et al, 2006) . Furthermore, a low penetrance and long latency of tumour induction indicated the requirement for additional neoplastic mutations, consistent with a multistep mechanism of leukemogenesis (De Keersmaecker et al, 2006; Van Vlierberghe et al, 2008) . In this latter regard, it has been found that the CDKN2A (INK4A-ARF) tumour suppressor locus is inactivated by homozygous or hemizygous deletion in most cases of TLX1 + disease (Sulong et al, 2008) . Also, >50% of all T-ALL cases-including TLX1 + samples-harbour activating mutations in the NOTCH1 gene (Weng et al, 2004) . Other recent work has identified two variant ABL1 fusion genes encoding constitutively activated tyrosine kinases Knockdown of TLX1 by shRNA affects growth and survival of ALL-SIL cells. (A) Western blot analysis of TLX1 protein levels (Cat. no. sc-880, Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in ALL-SIL cells stably expressing the TLX1 shRNA lentiviral vectors, TRCN0000014994 (94) and/or TRCN0000014995 (95) or the pLKO.1-puro (pLKO) lentiviral vector backbone. NS, nonspecific cross-reacting protein demonstrating equal loading. Following delivery of the TLX1 shRNA lentiviral vectors, polyclonal populations of cells were placed under puromycin selection (3 lg/ml). Analysis of TLX1 protein levels by Western blotting indicated that ALL-SIL cells stably expressing the 95 TLX1 shRNA had the greatest (>90%) degree of TLX1 knockdown. (B) TLX1 promotes growth of ALL-SIL cells. Cells were seeded at 1 · 10 5 /ml and viable cell counts after 4 days in culture are shown for the indicated populations (*P < 0.002, **P < 0.0006 vs. pLKO control). (C) TLX1 promotes survival of ALL-SIL cells. Cells were seeded at 6 · 10 4 /ml and apoptosis was measured on day 5 by flow cytometry after staining with annexin-phycoerythrin (PE) and 7-amino-actinomycin D (7-AAD) (PE Annexin V Apoptosis Detection Kit I, Cat. no. 559763, BD Biosciences, San Jose, CA) for the indicated populations (*P < 0.05 vs. pLKO control). (D) Western blot analysis of poly(ADP-ribose) polymerase 1 (PARP1) cleavage confirms increased apoptosis in ALL-SIL cells expressing the 95 TLX1 shRNA (P < 0.02 vs. pLKO control). PARP1 cleavage was detected by Western blotting with a PARP1 antibody (Cat. no. 9542, Cell Signaling Technology, Inc., Danvers, MA), in nuclear and cytosolic (hypotonic) extracts of the cell populations analysed in C. Full length PARP1 (116 kDa), as well as the large fragment of PARP1 resulting from caspase cleavage (89 kDa), are indicated ( ). Representative results of triplicate cell growth and apoptosis experiments are shown. Statistically significant differences were observed in separate experiments using the alamarBlue cell viability and proliferation reagent. Similar results were also obtained in independently-derived TLX1 knockdown ALL-SIL cells and in 95 TLX1 shRNA-expressing K3P cells. in many TLX1 + T-ALL cases (De Keersmaecker et al, 2006) ; and tandem duplication of the MYB transcription factor oncogene has also been described (Lahortiga et al, 2007) . The importance of these cooperative genetic aberrations in the multistep transformation of TLX1 + T-ALL is underscored by the ALL-SIL cell line (DSMZ no. ACC 511) (Riz & Hawley, 2005) , which carries all of these alterations (summarized in Owens et al, 2006) .
To gain a better understanding of the contribution of TLX1 to the malignant T-ALL phenotype, we downregulated TLX1
Knockdown of TLX1 by shRNA results in changes in the expression of CD1b, CD55 and CCR7 cell surface molecules on TLX1 + T-ALL cell lines. (A) ALL-SIL and K3P cells expressing the 95 TLX1 shRNA (red histograms) or the pLKO.1-puro lentiviral vector backbone (blue histograms) were analysed by flow cytometry after staining with anti-CD1b-Alexa Fluor 647 (Cat. no. 51-0018), anti-CD55-PE (Cat. no. 12-0559) or anti-CCR7fluorescein isothiocyanate (FITC) (Cat no. 11-1979) monoclonal antibodies (all from eBioscience, Inc., San Diego, CA). Green histograms represent unstained cell populations. Viable cells were gated by a combination of forward and orthogonal light scatter, and data was acquired on a FACSAria instrument (BD Biosciences) and analysed using WinList software (Verity Software House, Topsham, ME). Note the bimodal CD55 expression pattern in pLKO.1-puro-transduced ALL-SIL cells. Whereas CD1b and CD55 exhibited expression patterns following TLX1 knockdown consistent with a partial release of the early DP differentiation block, CCR7, the receptor for the medullary chemokines CCL19 and CCL21, is not normally expressed in early cortical thymocytes and represents a potential TLX1 target gene involved in T-ALL pathogenesis (see Table SII ). (B) ALL-SIL cells expressing the 95 TLX1 shRNA were viably sorted into CD1b hi CD55 lo and CD1b lo CD55 hi subpopulations. Whole cell extracts were prepared from aliquots of the sorted cells and TLX1 protein levels were analysed by Western blotting. CD1b lo CD55 hi cells expressed lower levels of TLX1. The membrane was reprobed with an antibody to actin (Cat. no. sc-8432, Santa Cruz Biotechnology, Inc.) to verify equal loading. Essentially identical results were obtained when the sorted CD1b hi CD55 lo and CD1b lo CD55 hi subpopulations were reanalysed after 14 days of culture, indicating that the acquired phenotypic changes associated with TLX1 knockdown remained stable. expression in ALL-SIL cells by lentiviral-mediated expression of short-hairpin RNAs (shRNAs) against TLX1 transcripts. Using a transient cotransfection luciferase reporter assay, we identified two TLX1 shRNA lentiviral vectors targeting the TLX1 coding region (designated 94 and 95), which resulted in c.60-70% knockdown of reporter expression ( Fig S1) . The 94 and 95 TLX1 shRNA lentiviral vectors, together with the pLKO.1-puro control lentiviral vector backbone, were produced as recombinant vector particles and used to stably transduce ALL-SIL cells. Reduced levels of TLX1 ( Fig 1A) were associated with decreased growth of TLX1 shRNAexpressing ALL-SIL cell populations ( Fig 1B) . Of note, annexin V staining revealed increased numbers of apoptotic cells in the TLX1 knockdown cultures ( Fig 1C) which correlated with increased cleavage of poly(ADP-ribose) polymerase 1 ( Fig 1D) . Importantly, the decreased fitness of the TLX1 knockdown ALL-SIL cells could not be rescued by ectopic expression of a fully active form (ICN1) of NOTCH1 (data not shown). The combined data thus demonstrated that, despite acquisition of multiple cooperating mutations and adaptation to continuous growth in culture, ALL-SIL cells remained partially dependent on (or were addicted to) TLX1 expression.
We next examined the effects of TLX1 knockdown on global transcript levels by conducting gene expression profiling of ALL-SIL cells stably expressing the 95 TLX1 shRNA and ALL-SIL cells expressing the empty pLKO.1-puro lentiviral vector. Complementary RNA from three independent cultures of the experimental and control ALL-SIL cell lines was hybridized to Affymetrix HG-U133 Plus 2AE0 GeneChip oligonucleotide arrays and analysis of expression data was performed as described previously (Riz & Hawley, 2005) . Of 46 genes that displayed ‡1AE9-fold changes in expression and had P-values £0AE05 for the three biological replicates (Tables SI  and SII) , 16 exhibited expression patterns following TLX1 knockdown consistent with a partial release of the early DP differentiation block (Table SI) by comparison to expression profiles obtained for sorted subpopulations of primary human thymocytes and mature T cells (GEO accession no. GSE1460). This is best exemplified by the changes in the expression patterns of the CD1B and CD1E genes, characteristically expressed by TLX1 + T-ALL clinical samples (Ferrando et al, 2002; Asnafi et al, 2004) . The CD1b and CD1e cell surface molecules, members of the lipid-presenting CD1 family of major histocompatibility complex (MHC)-class-I-like glycoproteins, become downregulated after TCR-mediated positive selection at the late DP stage of normal thymocyte development. In contrast, the CD55 gene, which encodes a glycosylphosphatidylinositol-anchored complement regulatory protein with signal transduction activity affecting a broad range of cellular properties, is an example of a gene that is more highly expressed in single positive thymocytes and mature T cells. For CD1B and CD55, the changes in mRNA expression detected by microarray profiling were validated at the level of the respective cell surface molecules by flow cytometric analysis (Fig 2A) . Besides ALL-SIL, there are only a few other TLX1 + T-ALL cell lines that have been described in the literature (K3P, PER-255 and SUP-T4). Amongst these, the K3P cell line was available for our studies (Riz & Hawley, 2005) . We were interested, therefore, in determining whether knockdown of TLX1 in K3P cells would also result in a partial release of the early cortical T-cell differentiation block. As can be seen in Fig 2A, K3P cells stably expressing the 95 TLX1 shRNA (>90% knockdown of TLX1 transcripts) exhibited irreversible downmodulation of CD1b cell surface levels concomitant with increased CD55 cell surface expression, paralleling the findings with ALL-SIL cells. To obtain further support of a direct relationship between TLX1 protein levels and the changes observed in CD1b and CD55 expression, ALL-SIL cells stably expressing the 95 TLX1 shRNA were viably sorted into CD1b hi CD55 lo and CD1b lo CD55 hi subpopulations. Our presumption was that the residual CD1b hi CD55 lo subpopulation was due to less efficient TLX1 knockdown (because of cell-to-cell variability in lentiviral vector-directed TLX1 shRNA expression) and consequently should express higher levels of TLX1 than the phenotypically more mature CD1b lo CD55 hi subpopulation. This prediction was confirmed by Western blotting for TLX1 ( Fig 2B) . We interpreted these results as direct evidence for a role of aberrant TLX1 expression in the early cortical DP differentiation block exhibited by TLX1 + T-ALL cells. 
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Keywords: TLX1 oncogene, T-cell acute lymphoblastic leukaemia, early CD1 + cortical thymocyte phenotype, TLX1 shRNA lentiviral vector. Fig S1. Comparison of relative knockdown efficacy of lentiviral vectors expressing shRNAs targeting the TLX1 coding region in a transient cotransfection luciferase reporter assay. A 623bp SmaI-XmnI fragment of the TLX1 coding region (GenBank Accession No. M62626) was subcloned into the PmeI site of the pMIR-REPORT luciferase reporter vector (Ambion, Inc.) downstream of the firefly luciferase coding sequence. Human embryonic kidney 293T cells (grown to 80% confluency in 6-well tissue culture plates) were cotransfected in triplicate with 1 ȝg reporter plasmid DNA plus 1 ȝg TLX1 shRNA lentiviral vector DNA per well using the FuGENE 6 Transfection Reagent (Roche Diagnostics Corp.) following the manufacturer's instructions, and incubated at 37°C in a humidified atmosphere containing 5% CO 2 for 48 h. The TLX1 shRNA lentiviral vectors tested included: TRCN0000014994 (designated #94), TRCN0000014995
(designated #95), TRCN0000014996 (designated #96) and TRCN0000014997 (designated #97) (MISSION™ TRC TLX1 shRNA target set, Cat. No. NM_005521, Sigma-Aldrich Co.). (Moffat et al, 2006) A fifth TLX1 shRNA lentiviral vector, TRCN0000014993 (designated #93), which targets sequences within the TLX1 3' untranslated region (not included in the subcloned fragment), served as a negative control. The Luciferase Assay System with Reporter Lysis Buffer (Cat. No. E4030; Promega Corp.) was used to detect luciferase activity according to the manufacturer's instructions. Luminescence intensities were quantitated with a Gemini XPS microplate spectrofluorometer equipped with SoftMax Pro software (Molecular Devices Corp.). The results were normalized with respect to samples cotransfected with the pMIR-REPORT luciferase reporter backbone and the respective TLX1 shRNA lentiviral vectors. Error bars represent standard deviations for triplicate samples. The data indicated that the #94 and #95 TLX1 shRNA lentiviral vectors reduced luciferase expression from the TLX1 target site reporter by ~60-70%. schlafen family member 5 2.5 *Mean fold changes in expression levels between ALL-SIL cells expressing the #95 TLX1 shRNA and ALL-SIL cells transduced with the pLKO.1-puro lentiviral vector backbone (n = 3 pairs of biological replicates; P 0.05). Relative levels of expression were compared to gene expression profiles obtained for sorted subpopulations of primary human thymocytes and mature T cells (NCBI GEO accession no. GSE1460). All of the microarray data has been deposited in the Public Expression Profiling Resource (http://pepr.cnmcresearch.org/). *Mean fold changes in expression levels between ALL-SIL cells expressing the #95 TLX1 shRNA and ALL-SIL cells transduced with the pLKO.1-puro lentiviral vector backbone (n = 3 pairs of biological replicates; P 0.05). All of the microarray data has been deposited in the Public Expression Profiling Resource (http://pepr.cnmcresearch.org/). † CCR7, the receptor for the medullary chemokines CCL19 and CCL21, is induced on late cortical DP cells upon TCR-mediated positive selection and, along with CD62L, mediates homing of recent thymic emigrants to secondary lymphoid organs. Of particular relevance, inappropriate expression of Ccr7 during murine thymocyte differentiation mislocalizes DP cells from the cortex into the medulla, accompanied by impaired development of single positive T cells (Kwan & Killeen, 2004) . Intriguingly, a recent high-throughput leukemogenesis screen in mice using retroviral insertional mutagenesis has identified Ccr7 as a candidate oncogene (Uren et al, 2008) . ‡ FHL1 is a member of the four-and-a-half LIM domain protein family, the murine ortholog of which (Fhl1/Slim1) was originally found to be activated by exogenous TLX1 expression in mouse NIH3T3 fibroblasts (Greene et al, 1998) and, in separate studies, shown to inhibit differentiation of primary mouse keratinocytes (Grossi et al, 2005) .
